Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2024-02-15 2024-02-15
Drug Identification Number 02507218 02507218
Brand name TEVA-RIVAROXABAN TEVA-RIVAROXABAN
Common or Proper name RIVAROXABAN 15MG TAB RIVAROXABAN 15MG TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients RIVAROXABAN RIVAROXABAN
Strength(s) 15MG 15MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 3x10 3x10
ATC code B01AF B01AF
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-02-14 2024-02-14
Estimated end date 2024-05-31 2024-05-31
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments